Currently Viewing:
Supplements The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics?
The Debate
The Great Debate Part II
Diana I. Brixner, RPh, PhD; Leslie Fish, RPh, PharmD; and Wayne M. Lednar, MD, PhD
The Case for Cost Sharing for Biologic Therapies
Leslie Fish, RPh, Pharm D
The Case Against Excessive Cost Sharing
Diana I. Brixner, RPh, PhD
Balancing Quality Employee Benefits With Cost Sharing
Wayne M. Lednar, MD, PhD
The Great Debate Part II: Should Managed Care Rely on Cost Sharing to Manage Big-ticket Biologics?
Mark Zitter, MBA
CE/CME Quiz
Currently Reading
Participating Faculty

Participating Faculty

This supplement to The American Journal of Managed Care is based partly on a moderated session held at the annual meeting of the Academy of Managed Care Pharmacy, October 7, 2005, in Nashville, Tennessee. This supplement has been prepared with writing and editorial services of the The Zitter Group. It has been peer reviewed by an expert in the field.

Faculty

  • Diana I. Brixner, RPh, PhD
    Associate Professor and Chair
    Department of Pharmacotherapy
    Executive Director
    Pharmacotherapy Outcomes Research Center
    University of Utah College of Pharmacy
    Salt Lake City, Utah
  • Leslie Fish, RPh, PharmD
    Director of Pharmacy Services
    Fallon Community Health Plan
    Worchester, Massachusetts
  • Wayne M. Lednar, MD, PhD
    Vice President
    Chief Medical Director
    Eastman Kodak Company
    Rochester, New York
  • Mark Zitter, MBA
    CEO
    The Zitter Group
    Millburn, New Jersey

Faculty Disclosures

Diana I. Brixner, RPh, PhD, reports that she (nor does any immediate family member) does not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity or any affiliation with an organization whose philosophy could potentially bias her involvement in this activity.

Leslie Fish, RPh, PharmD, reports that she (nor does any immediate family member) does not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity or any affiliation with an organization whose philosophy could potentially bias her involvement in this activity.

Wayne M. Lednar, MD, PhD, reports that he (nor does any immediate family member) does not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity or any affiliation with an organization whose philosophy could potentially bias his involvement in this activity.

Mark Zitter, MBA, reports that he has (or an immediate family member has) a vested interest in or affiliation with a corporate organization offering financial support or grant monies for this continuing education activity or with an organization that has a specific interest in the therapeutic areas under discussion as follows: his company, The Zitter Group, sells services or products to most major biotechnology firms. He is also a consultant for Genentech.

Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The University of Utah College of Pharmacy and the University of Utah School of Medicine do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Utah College of Pharmacy or the University of Utah School of Medicine. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Americans with Disabilities Act (ADA): The University of Utah College of Pharmacy and the University of Utah School of Medicine complies with the ADA by providing qualified individuals with disabilities access to University programs, services, and activities. A request for accommodation can be made by calling (801) 483-3039. Reasonable prior notice is required.

PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up